Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000820096-12-000022
Filing Date
2012-11-07
Accepted
2012-11-07 11:35:32
Documents
11
Period of Report
2012-09-29

Document Format Files

Seq Description Document Type Size
1 10-Q a2013q110q.htm 10-Q 1059989
2 FIRST AMENDMENT TO CREDIT AGREEMENT a2013q1ex101.htm EX-10.1 62385
3 RULE 13A-14(A) CERTIFICATIONS a2013q1ex31.htm EX-31 12159
4 RULE 13A-14(A) CERTIFICATIONS a2013q1ex311.htm EX-31.1 12166
5 SECTION 1350 CERTIFICATIONS a2013q1ex32.htm EX-32 9107
  Complete submission text file 0000820096-12-000022.txt   8562676

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prgo-20120929.xml EX-101.INS 1506872
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20120929.xsd EX-101.SCH 41481
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20120929_cal.xml EX-101.CAL 82432
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20120929_def.xml EX-101.DEF 312516
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20120929_lab.xml EX-101.LAB 640679
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20120929_pre.xml EX-101.PRE 366990
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address 515 EASTERN AVENUE ALLEGAN MI 49010 2696738451
PERRIGO CO (Filer) CIK: 0000820096 (see all company filings)

EIN.: 382799573 | State of Incorp.: MI | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-19725 | Film No.: 121185500
SIC: 2834 Pharmaceutical Preparations